These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
863 related articles for article (PubMed ID: 23539443)
1. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443 [TBL] [Abstract][Full Text] [Related]
2. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. Mizutani A; Yashiroda Y; Muramatsu Y; Yoshida H; Chikada T; Tsumura T; Okue M; Shirai F; Fukami T; Yoshida M; Seimiya H Cancer Sci; 2018 Dec; 109(12):4003-4014. PubMed ID: 30238564 [TBL] [Abstract][Full Text] [Related]
3. Tanaka N; Mashima T; Mizutani A; Sato A; Aoyama A; Gong B; Yoshida H; Muramatsu Y; Nakata K; Matsuura M; Katayama R; Nagayama S; Fujita N; Sugimoto Y; Seimiya H Mol Cancer Ther; 2017 Apr; 16(4):752-762. PubMed ID: 28179481 [TBL] [Abstract][Full Text] [Related]
4. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753 [TBL] [Abstract][Full Text] [Related]
5. Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes. Thorvaldsen TE; Pedersen NM; Wenzel EM; Schultz SW; Brech A; Liestøl K; Waaler J; Krauss S; Stenmark H Mol Cancer Res; 2015 Nov; 13(11):1487-501. PubMed ID: 26124443 [TBL] [Abstract][Full Text] [Related]
6. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase. Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752 [TBL] [Abstract][Full Text] [Related]
7. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Ma L; Wang X; Jia T; Wei W; Chua MS; So S Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473 [TBL] [Abstract][Full Text] [Related]
8. mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer. Mashima T; Taneda Y; Jang MK; Mizutani A; Muramatsu Y; Yoshida H; Sato A; Tanaka N; Sugimoto Y; Seimiya H Oncotarget; 2017 Jul; 8(29):47902-47915. PubMed ID: 28615517 [TBL] [Abstract][Full Text] [Related]
9. Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase. Jang MK; Mashima T; Seimiya H Mol Cancer Ther; 2020 Mar; 19(3):765-776. PubMed ID: 31907221 [TBL] [Abstract][Full Text] [Related]
10. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells. Chen M; Mashima T; Oishi T; Muramatsu Y; Seto Y; Takamatsu M; Kawata N; Morino S; Nakamura A; Inaba S; Yuan X; Maruyama K; Suzuki M; Sato A; Yoshida H; Jang MK; Mizutani A; Takeuchi K; Yamaguchi K; Shirai F; Nagayama S; Katayama R; Seimiya H Br J Cancer; 2024 Jan; 130(1):151-162. PubMed ID: 37968472 [TBL] [Abstract][Full Text] [Related]
12. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt. Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726 [TBL] [Abstract][Full Text] [Related]
13. Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract. Kim DY; Kwon YJ; Seo WY; Kim UI; Ahn S; Choi SM; Bang HT; Kim K; Kim JS Eur J Cancer; 2022 Sep; 173():41-51. PubMed ID: 35849876 [TBL] [Abstract][Full Text] [Related]
14. Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta. Martino-Echarri E; Brocardo MG; Mills KM; Henderson BR PLoS One; 2016; 11(3):e0150484. PubMed ID: 26930278 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells. Bao R; Christova T; Song S; Angers S; Yan X; Attisano L PLoS One; 2012; 7(11):e48670. PubMed ID: 23144924 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin. Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951 [TBL] [Abstract][Full Text] [Related]